Estimating the population benefit of radiotherapy: using demand models to estimate achievable cancer outcomes.

作者: T.P. Hanna , J. Shafiq

DOI: 10.1016/J.CLON.2014.10.011

关键词:

摘要: The measurement of population benefits is important for priority setting, economic evaluation and quality improvement. It also informs advocacy. In this article, the use demand models to estimate achievable benefit cancer therapy reviewed. Achievable refers treatment under optimal conditions. radiotherapy has been used as an example. Demand provide a means estimating proportion patients with indications when guidelines are followed. They may be benefit. choice end point should reflect range associated interest. some cases, further model development needed if pre-existing used. each indication estimated using systematic review process. highest level evidence define indication. cases where multiple sources same exist, meta-analysis carried out. Population-based effectiveness data considered, but three major challenges their are: (i) generalisability observed outcomes, (ii) resolution (iii) confounding bias. determined from process describes achieving due guideline-based treatment, compared no that treatment. Sensitivity analysis provides modelling effect uncertainties. predominant uncertainty most often in proportion. Preference-sensitive decisions common described approach robust uncertainties, rapidly adaptable transparent. However, estimates rely on affected by assumptions. Models developed broader modalities relevant points.

参考文章(28)
Milo A Puhan, Ravi Varadhan, Sonal Singh, Carlos O Weiss, Eric B Bass, Cynthia M Boyd, Ritu Sharma, Methods for Benefit and Harm Assessment in Systematic Reviews Agency for Healthcare Research and Quality (US). ,(2012)
Martina Garau, Koonal K. Shah, Anne R. Mason, Qing Wang, Adrian Towse, Michael F. Drummond, Using QALYs in cancer: a review of the methodological limitations. PharmacoEconomics. ,vol. 29, pp. 673- 685 ,(2011) , 10.2165/11588250-000000000-00000
Geoff Delaney, Susannah Jacob, Carolyn Featherstone, Michael Barton, The role of radiotherapy in cancer treatment Cancer. ,vol. 104, pp. 1129- 1137 ,(2005) , 10.1002/CNCR.21324
Joel E. Tepper, Leonard L. Gunderson, Clinical Radiation Oncology ,(2000)
Sharlyn Kang, Eng-Siew Koh, Shalini K. Vinod, Bin Jalaludin, Cost analysis of lung cancer management in South Western Sydney. Journal of Medical Imaging and Radiation Oncology. ,vol. 56, pp. 235- 241 ,(2012) , 10.1111/J.1754-9485.2012.02354.X
Scott Tyldesley, Geoff Delaney, Farshad Foroudi, Lisa Barbera, Marc Kerba, William Mackillop, Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia. International Journal of Radiation Oncology Biology Physics. ,vol. 79, pp. 1507- 1515 ,(2011) , 10.1016/J.IJROBP.2009.12.070
Xue Q. Yu, Dianne L. O'Connell, Robert W. Gibberd, David P. Smith, Paul W. Dickman, Bruce K. Armstrong, Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes & Control. ,vol. 15, pp. 611- 618 ,(2004) , 10.1023/B:CACO.0000036165.13089.E8
Jean-Pierre Pignon, Aurélie le Maître, Jean Bourhis, Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. International Journal of Radiation Oncology Biology Physics. ,vol. 69, ,(2007) , 10.1016/J.IJROBP.2007.04.088
Lisa Barbera, Jina Zhang-Salomons, Jenny Huang, Scott Tyldesley, William Mackillop, Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach. Medical Care. ,vol. 41, pp. 1074- 1085 ,(2003) , 10.1097/01.MLR.0000083742.29541.BC
Danielle Rodin, David Jaffray, Rifat Atun, Felicia M Knaul, Mary Gospodarowicz, The need to expand global access to radiotherapy Lancet Oncology. ,vol. 15, pp. 378- 380 ,(2014) , 10.1016/S1470-2045(14)70121-4